JP2017532043A5 - - Google Patents

Download PDF

Info

Publication number
JP2017532043A5
JP2017532043A5 JP2017519813A JP2017519813A JP2017532043A5 JP 2017532043 A5 JP2017532043 A5 JP 2017532043A5 JP 2017519813 A JP2017519813 A JP 2017519813A JP 2017519813 A JP2017519813 A JP 2017519813A JP 2017532043 A5 JP2017532043 A5 JP 2017532043A5
Authority
JP
Japan
Prior art keywords
erf1
combination
mutant erf1
mutant
unnatural amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017519813A
Other languages
English (en)
Japanese (ja)
Other versions
JP6843044B2 (ja
JP2017532043A (ja
Filing date
Publication date
Priority claimed from GBGB1419109.2A external-priority patent/GB201419109D0/en
Application filed filed Critical
Publication of JP2017532043A publication Critical patent/JP2017532043A/ja
Publication of JP2017532043A5 publication Critical patent/JP2017532043A5/ja
Application granted granted Critical
Publication of JP6843044B2 publication Critical patent/JP6843044B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017519813A 2014-10-27 2015-10-21 非天然アミノ酸のタンパク質への組み込み Active JP6843044B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1419109.2A GB201419109D0 (en) 2014-10-27 2014-10-27 Incorporation of unnatural amino acids into proteins
GB1419109.2 2014-10-27
PCT/GB2015/053141 WO2016066995A1 (en) 2014-10-27 2015-10-21 Incorporation of unnatural amino acids into proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020177605A Division JP2021035374A (ja) 2014-10-27 2020-10-22 非天然アミノ酸のタンパク質への組み込み

Publications (3)

Publication Number Publication Date
JP2017532043A JP2017532043A (ja) 2017-11-02
JP2017532043A5 true JP2017532043A5 (enExample) 2018-10-25
JP6843044B2 JP6843044B2 (ja) 2021-03-17

Family

ID=52103474

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017519813A Active JP6843044B2 (ja) 2014-10-27 2015-10-21 非天然アミノ酸のタンパク質への組み込み
JP2020177605A Withdrawn JP2021035374A (ja) 2014-10-27 2020-10-22 非天然アミノ酸のタンパク質への組み込み

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020177605A Withdrawn JP2021035374A (ja) 2014-10-27 2020-10-22 非天然アミノ酸のタンパク質への組み込み

Country Status (9)

Country Link
US (1) US10738339B2 (enExample)
EP (1) EP3212799B1 (enExample)
JP (2) JP6843044B2 (enExample)
KR (1) KR102516695B1 (enExample)
CN (1) CN107002088B (enExample)
BR (1) BR112017008108A2 (enExample)
CA (1) CA2965085A1 (enExample)
GB (1) GB201419109D0 (enExample)
WO (1) WO2016066995A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6343604B2 (ja) 2012-05-18 2018-06-13 メディカル リサーチ カウンシル BCN基を含むアミノ酸をコードする直交性コドンと、直交性PylRS合成酵素とを使用して、BCN基を含むアミノ酸をポリペプチドに取り込む方法
GB2528227A (en) 2014-03-14 2016-01-20 Medical Res Council Cyclopropene amino acids and methods
WO2018044143A1 (ko) * 2016-09-05 2018-03-08 한국과학기술원 목적 단백질의 위치 특이적 변형이 시공간적으로 조절되는 마우스, 이의 제조방법 및 그 용도
CN106834349B (zh) * 2017-02-28 2019-12-13 中国人民解放军军事医学科学院 一种安全性提高的病毒基因递送系统
CN117286182A (zh) * 2017-06-02 2023-12-26 Ambrx公司 促进含非天然氨基酸的蛋白质产生的方法和组合物
CN119410679A (zh) * 2018-05-01 2025-02-11 Ambrx公司 一种用于优化抗体表达的方法
US20210356377A1 (en) * 2018-09-07 2021-11-18 Medimmune, Llc Methods Of Cell Selection
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
EP3696189A1 (en) * 2019-02-14 2020-08-19 European Molecular Biology Laboratory Means and methods for preparing engineered target proteins by genetic code expansion in a target protein selective manner
CN111718949B (zh) * 2019-03-19 2021-10-01 宁波鲲鹏生物科技有限公司 利用双质粒系统在蛋白中引入非天然氨基酸
CN111850020B (zh) * 2019-04-25 2021-05-07 苏州鲲鹏生物技术有限公司 利用质粒系统在蛋白中引入非天然氨基酸
CN111849929B (zh) * 2019-04-30 2021-05-11 苏州鲲鹏生物技术有限公司 高效引入赖氨酸衍生物的氨酰基—tRNA合成酶
GB201906775D0 (en) 2019-05-14 2019-06-26 Res & Innovation Uk Synthetic genome
TW202128996A (zh) * 2019-10-10 2021-08-01 美商史基普研究協會 用於活體內合成非天然多肽的組合物及方法
CN117881779A (zh) 2021-05-28 2024-04-12 英国研究与创新署 微生物及其用途
CN113481239A (zh) * 2021-07-01 2021-10-08 四川大学华西医院 一种通过Rosa26位点向细胞系中引入非天然氨基酸编码体系的方法及其细胞系
AU2022306337A1 (en) * 2021-07-07 2024-02-01 Ajinomoto Co., Inc. Method for secretory production of unnatural-amino-acid-containing protein
GB202110137D0 (en) 2021-07-14 2021-08-25 Res & Innovation Uk Methods for optimising protein production
CN113699124B (zh) * 2021-09-08 2022-04-12 北京大学 一种含非天然氨基酸蛋白的制备方法
EP4504926A2 (en) * 2022-04-08 2025-02-12 ABSCI Corporation Trna synthetases and methods of use thereof
WO2024199465A1 (en) * 2023-03-30 2024-10-03 The Chinese University Of Hong Kong Unnatural amino acid in cellulo synthesis for site-specific protein modification
CN120752342A (zh) * 2023-07-13 2025-10-03 深圳华大生命科学研究院 工程生物遏制系统及方法
CN120210144A (zh) * 2023-12-25 2025-06-27 康码(上海)生物科技有限公司 一种改造的氨酰-tRNA合成酶、核酸构建物以及基因工程菌株

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0417801A (pt) * 2003-12-18 2007-04-10 Scripps Research Inst incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas
AU2005330514B2 (en) * 2004-10-27 2011-05-12 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
CA2706889C (en) 2007-09-20 2018-08-28 Riken Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
GB2470770A (en) 2009-06-04 2010-12-08 Medical Res Council Incorporation of unnatural amino acids having an orthogonal functional group into polypeptides using orthogonal tRNA/tRNA synthetase pairs
US20120077186A1 (en) 2010-05-07 2012-03-29 Oregon Health & Science University Use of cysteine-derived suppressor trnas for non-native amino acid incorporation
GB201201100D0 (en) 2012-01-20 2012-03-07 Medical Res Council Polypeptides and methods

Similar Documents

Publication Publication Date Title
JP2017532043A5 (enExample)
BR112017008108A2 (pt) incorporação de aminoácidos não naturais em proteínas
JP2008525024A5 (enExample)
Athmaram et al. Influence of copy number on the expression levels of pandemic influenza hemagglutinin recombinant protein in methylotrophic yeast Pichia pastoris
MX2022007858A (es) Polipeptidos efectores crispr-cas y metodos de uso de estos.
PH12018502361A1 (en) Gdf15 fusion proteins and uses thereof
MX366910B (es) Metodos de fabricacion para controlar el contenido de lisina c-terminal, galactosa y acido sialico en proteinas recombinantes.
WO2009091912A3 (en) Improved mammalian expression vectors and uses thereof
WO2008127179A8 (en) Fusion protein vaccine
WO2016130628A8 (en) Griffithsin mutants
AU2018253611A1 (en) Engineered pesticidal proteins
RU2017102986A (ru) Новые люциферазы и способы их использования
MX2021003021A (es) Polipéptidos insecticidas mutantes de av3 y métodos para producción y uso de los mismos.
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
MX2021002135A (es) Secuencia génica de gtpasa similar a dineína mitocondrial de tipo ii humana recombinante y usos de esta.
WO2012036391A3 (ko) 돼지 써코바이러스2(pcv2) 유전자의 표면발현용 벡터 및 이로 형질전환된 살모넬라 백신 균주
WO2023250384A3 (en) Crispr-cas effector polypeptides and methods of use thereof
JP2011507507A (ja) マルチマー性前駆体のinvivoタンパク質分解的プロセシングによる関心対象のタンパク質の分泌収量の改善
CN103194442B (zh) 新型多肽、水解抗菌肽及其制备方法
EA201792274A1 (ru) Слитые молекулы вариант iii рецептора эпидермального фактора роста-мезотелин и способы их применения
JP2017524366A5 (enExample)
Niu et al. The molecular design of a recombinant antimicrobial peptide CP and its in vitro activity
WO2010079982A3 (ko) repE 변이유전자를 함유하는 항시적 고발현 벡터
JPWO2007026617A1 (ja) 発現ベクター、それを導入した形質転換体、および異種タンパク質の製造方法
WO2020210480A3 (en) Factor h vectors and uses thereof